Literature DB >> 10629541

Is dedifferentiated chondrosarcoma a 'de-differentiated' chondrosarcoma?

T Aigner, K K Unni.   

Abstract

Since its first description 30 years ago, dedifferentiated chondrosarcoma has been the prototype of all dedifferentiated sarcomas. The presence of two tumour portions of different mesenchymal differentiation lineages in these neoplasms gives rise to three key questions, which are on the way to being resolved. Does it split up? And if so, how does it split up and when does it split up? Accumulating data provide evidence for a common monoclonal origin of both tumour portions and suggest that dedifferentiated chondrosarcoma is a paradigmatic neoplasm of mesenchymal transdifferentiaton in vivo. Two categories emerge of dedifferentiated chondrosarcomas with different cell biology: the classical one, with a low-grade chondroid component splitting up late, and a second type, with a high-grade chondroid component splitting up early in tumour development. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10629541     DOI: 10.1002/(SICI)1096-9896(199912)189:4<445::AID-PATH468>3.0.CO;2-M

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Dedifferentiated chondrosarcoma--a fatal disease.

Authors:  J Bruns; W Fiedler; M Werner; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

2.  Dedifferentiated chondrosarcoma of the ring finger: a case report of an exceptional surgical treatment and review of literature.

Authors:  Olimpia Mani; Lorenzo Andreani; Antonio D'Arienzo; Simone Colangeli; Rodolfo Capanna
Journal:  Orthop Rev (Pavia)       Date:  2022-04-25

3.  Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis.

Authors:  Lu Gao; Xiafei Hong; Xiaopeng Guo; Dengfeng Cao; Xiaohuan Gao; Thomas F DeLaney; Xinqi Gong; Rongrong Chen; Jianjiao Ni; Yong Yao; Renzhi Wang; Xi Chen; Pangzehuan Tian; Bing Xing
Journal:  Oncotarget       Date:  2016-07-12

4.  Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.

Authors:  Lei Cao; Yuan Wu; Shu-Man Han; Tao Sun; Bao-Hai Yu; Feng Gao; Wen-Juan Wu; Bu-Lang Gao
Journal:  BMC Musculoskelet Disord       Date:  2021-02-15       Impact factor: 2.362

5.  Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.

Authors:  Naoko Kudo; Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Wenguang Gu; Hajime Umezu; Tsuyoshi Toyama; Naoto Endo
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.535

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.